It Pays to be Thin

Podcast Summary

In this episode, we tackle some hot topics and share inspiring stories. We start with a big piece of news: the CEO of Novo Nordisk being brought before a Senate committee. This is huge because Novo Nordisk is a major player in the GLP-1 medication world, and there's a lot of scrutiny on how these drugs are priced and covered by insurance. We also dive into the incredible story of Leslie, who needed a combination of nutrition, exercise, GLP-1 medications, and bariatric surgery to lose an aston...

In this episode of The Pound of Cure Podcast, Dr. Matthew Weiner and Zoë Schroeder discuss the practical weight loss lessons behind It Pays to be Thin. The conversation connects medical weight loss, bariatric surgery, GLP-1 medications, nutrition, and long-term metabolic health.

Patients who are comparing treatment options can use this episode to better understand how evidence-based obesity care works in real life, including the role of food quality, medication support, surgery, mindset, and ongoing follow-up.

More from this episode

This episode includes a full transcript. The detailed episode guide should be regenerated from that transcript when AI summary generation is available.

Weight loss topics covered in this episode

This conversation is part of the Pound of Cure approach to evidence-based weight loss education, including bariatric surgery, GLP-1 medications, nutrition counseling, metabolic health, and long-term patient support.

For more context, explore our guides to GLP-1 medications, bariatric surgery in Tucson, and the Metabolic Reset Diet.